| [1]Carlisle EM. Silicon: an essential element for the chick. Science. 1972; 178: 619-621.[2]Carlisle EM. Silicon as a trace nutrient. Sci Total Environ. 1988; 73: 95-106.[3]Schwarz K. A bound form of silicon in glycosaminoglycans and polyuronides. Proc Natl Acad Sci. 1973; 70: 1608-1612.[4]Carlisle EM. Silicon as an essential element. Fed Proc. 1974; 33: 1758-1766.[5]Carlisle EM. In vivo requirement for silicon in articular cartilage and connective tissue formation in the chick. J Nutr. 1976; 106: 478-484.[6]Carlisle EM. Silicon. Nutr Rev.1975; 33: 257-261.[7]Landis WJ, Lee DD, Brenna JT, et al. Detection and localization of silicon and associated elements in vertebrate bone tissue by imaging ion microscopy. Calcif Tissue Int.1986; 38: 52-59.[8]Policard A, Collet A, Daniel Moussard H, et al. Deposition of silica in mitochondria: an electron microscopic study.J Biophys Biochem Cytol.1961; 9: 236-238.[9]Arumugam MQ, Ireland DC, Brooks RA,et al. Orthosilicic acid increases collagen type I mRNA expression in human bone-derived osteoblasts in vitro.Key Eng Mater. 2006; 254: 869-872.[10]Reffitt DM, Ogston N, Jugdaohsingh R,et al.Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone. 2003; 32: 127-135.[11]Jugdaohsingh R, Reffitt DM, Oldham C,et al. Oligomeric but not monomeric silica prevents aluminum absorption in humans. Am J Clin Nutr.2000; 71: 944-949.[12]Buchman AL, Howard LJ, Guenter P,et al. Micronutrients in parenteral nutrition: too little or too much? The past, present, and recommendations for the future. Gastroenterology. 2009; 137: S1-6.[13]Carlisle EM, Suchil C. Silicon and ascorbate interaction in cartilage formation in culture. Fed Proc.1983; 42: 398.[14]Lia H,Changa J.Bioactive silicate materials stimulate angiogenesis in fibroblast and endothelial cell co-culture system through paracrine effect. Acta Biomater.2013; 9: 6981-6991.[15]Bouletreau PJ, Warren SM, Spector JA,et al.Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg.2002; 109: 2384-2397.[16]Henstock JR, Ruktanonchai UR, Canham LT,et al. Porous silicon confers bioactivity to polycaprolactone composites in vitro.J Mater Sci Mater Med.2014; 25: 1087-1097.[17]Scarfi S, Benatti U, Pozzolini M,et al. Ascorbic acid-pretreated quartz enhances cyclo-oxygenase-2 expression in RAW 264.7 murine macrophages. FEBS J. 2007; 274: 60-73.[18]Landis WJ, Glimcher MJ. Electron diffractiona and electron probe microanalysis of the mineral phase of bone tissue prepared by anhydrous techniques. J Ultrastruct Res.1978; 63: 188-223.[19]Ratner BD, Hoffman AS, Schoen FJ,et al. Biomaterials science: an introduction to materials in medicine. New York: Academic Press; 2004.[20]Boivin G. The hydroxyapatite crystal: a closer look. Medicographia. 2007; 29: 126-132.[21]Shepherd JH, Shepherd DV, Best SM. Substituted hydroxyapatites for bone repair. J Mater Sci Mater Med. 2012; 23: 2335-2347.[22]Jugdaohsingh R, Tucker KL, Qiao N,et al. Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort.J Bone Min Res.2004; 19: 297-307.[23]Birchall JD. The essentiality of silicon in biology. Chem Soc Rev. 1995; 24: 351-357.[24]Elliot MA, Edwards HM. Effect of dietary silicon on growth and skeletal development in chickens. J Nutr. 1991; 121: 201-207.[25]Hench LL. The story of Bioglass. J Mater Sci-Mater Med. 2006; 17: 967-978.[26]Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater 2013; 9: 4457-486.[27]Lopez-Esteban A, Saiz E, Fujino S,et al. Bioactive glass coatings for orthopaedic metallic implants.J Eur Ceram Soc. 2003; 23: 2921-2930.[28]Thomas MV, Puleo DA, Al-Sabbagh M. Bioactive glass three decades on. J Long Term Eff Med Implants. 2005; 15: 585-597.[29]Loty C, Sautier J-M, Boulekbache H,et al. In vitro bone formation on a bone-like apatite layer prepares by a biomimetic process on a bioactive glass-ceramic. J Biomed Mater Res.1999; 49: 423-434.[30]Xynos IE, Alasdair JE, Buttery LDK,et al. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5. J Biomed Mater Res. 2001; 55: 151-157.[31]Gough JE, Downes S. Osteoblast cell death on methacrylate polymers involves apoptosis.J Biomed Mater Res, Part A. 2001;15: 497-505.[32]Valerio P, Pereira MM, Goes AM,et al. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials. 2004; 25: 2941-2948.[33]Nakasaki M, Yoshioka K, Miyamoto Y,et al. IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone. 2008; 43: 869-879.[34]Fiedler J, Roderer G, Gunther KP,et al. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem. 2002; 87: 305-312.[35]Rosengren A, Oscarsson S, Mazzocchi M,et al. Protein adsorption onto two bioactive glass-ceramics. Biomaterials. 2003; 24: 147-155.[36]Misra SK, Mohn D, Brunner TJ,et al. Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites. Biomaterials 2008;29: 1750-1761.[37]Lobell KD, Hench LL. In vitro adsorption and activity of enzymes on reaction layers of bioactive glass substrates. J Biomed Mater Res, Part A.1998; 39: 575-579.[38]Manzano M, Lozano D, Arcos D,et al.Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings. Acta Biomater.2011; 7: 3555-3562.[39]Soderling E, Herbst K, Larmas E,et al. Protein adsorption to a bioactive glass with special reference to precorrosion. J Biomed Mater Res, Part A.1996; 31: 525-531.[40]Anderson SI, Downes S, Perry CC,et al. Evaluation of the osteoblast response to a silica gel in vitro. J Mater Sci Mater Med. 1998; 9: 731-735.[41]Li P, Nakanishi K, Kokubo T,et al. Induction and morphology of hydroxyapatite, precipitated from metastable simulated body fluids on sol-gel prepared silica. Biomaterials. 1993; 14: 963-968.[42]Rosenholm JM, Mamaeva V, Sahlgren C, et al. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage. Nanomedicine. 2012; 7(1): 111-120.[43]Seo YH, Nahm KS, An MH, et al. Formation mechanism and pore size control of light-emitting porous silicon.J Appl Phys. 1994; 33: 6425-6431.[44]Canham LT. Properties of porous silicon. London: Inspec, IEE; 1997.[45]Serda RE, Gu J, Bhavane RC, Liu X, et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials. 2009; 30: 2440-2448.[46]Zhang K, Loong SL, Connor S, et al. Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice. Clin Cancer Res. 2005; 11: 7532-7537.[47]Canham LT, Aston R. Will a chip every day keep the doctor away?. Phys World. 2001: 27-31.[48]Jaganathan H, Godin B. Biocompatibility assessment of Si-based nano- and micro-particles. Adv Drug Deliv Rev.2012; 64(15): 1800-1819.[49]Whitehead MA, Fan D, Mukherjee P,et al. Highporosity poly(epsilon-caprolactone)/mesoporous silicon scaffolds: calcium phosphate deposition and biological response to bone precursor cells. Tissue Eng Part A. 2008; 14: 195-206.[50]Johansson F, Kanje M, Linsmeier CE,et al. The influence of porous ilicon on axonal outgrowth in vitro. IEEE Trans Biomed Eng.2008; 55: 1447-1449. [51]Alvarez SD, Derfus AM, Schwartz MP,et al. The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors. Biomaterials. 2008; 30: 26-34.[52]Shabir Q, Skaria C, O’Brien H,et al. Taste and mouthfeel assessment of porous and non-porous silicon microparticles. Nanoscale Res Lett.2012; 7: 407.[53]Low SP, Voelcker NH, Canham LT,et al. The biocompatibility of porous silicon in tissues of the eye. Biomaterials. 2009; 30: 2873-2880.[54]Park JH, Gu L, von Maltzahn G,et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater.2009; 8: 331-336.[55]Bohner M. Silicon-substituted calcium phosphates–a critical view. Biomaterials. 2009; 30: 6403-6406.[56]Gibson IR, Best SM, Bonfield W. Chemical characterization of siliconsubstituted hydroxyapatite. J Biomed Mater Res.1999; 44: 422-428.[57]Thian ES, Huang J, Best SM,et al. Silicon-substituted hydroxyapatite: The next generation of bioactive coatings. Mater Sci Eng, C. 2007; 27: 251-256.[58]Zhang E, Zou C. Porous titanium and silicon-substituted hydroxyapatite biomodification prepared by a biomimetic process: characterization and in vivo evaluation. Acta Biomater. 2009; 5: 1732-1741.[59]Botelho CM, Brooks RA, Best SM,et al. Human osteoblast response to silicon-substituted hydroxyapatite.J Biomed Mater Res,Part A.2006; 79: 723-730.[60]Porter AE, Patel N, Skepper JN, et al. Effect of sintered silicatesubstituted hydroxyapatite on remodelling processes at the bone-implant interface. Biomaterials. 2004; 25: 3303-3314.[61]Gibson IR, Best SM, Bonfield W. Effect of silicon substitution on the sintering and microstructure of hydroxyapatite. J Am Ceram Soc.2002; 85: 2771-2777.[62]Porter AE, Patel N, Skepper JN, et al. Comparison of in vivo dissolution processes in hydroxyapatite and silicon-substituted hydroxyapatite bioceramics. Biomaterials. 2003; 24: 4609-4620.[63]Janowsky EC, Kupper LL, Hulka BS. Meta-analysis of the relation between silicon breast implants and the risk of connected tissue diseases. N Eng J Med. 2000; 342(11): 781-790.[64]Lugowksi SJ, Smith DC, Bonek H,et al. Analysis of silicon in human tissues with special reference to silicone breast implants. J Trace Elem Med Biol.2000; 14: 31-42.[65]Heublein B, Ozbek C, Pethig K. Silicon carbide-coated stents: clinical experience in coronary lesions with increased thrombotic risk. J Endovasc Surg. 1998; 5: 32-36.[66]Webster TJ, Patel AA, Rahaman MN, et al. Anti infective and osteointegration properties of silicon nitride, poly(ether ether ketone) and titanium implants. Acta Biomater. 2012; 8(12): 4447-4454.[67]Olofsson J, Grehk TM, Berlind T,et al. Evaluation of silicon nitride as a wear resistant and resorbable alternative for total hip joint replacement. Biomatter. 2012; 2(2): 1-9.[68]Thomas MV, Puleo DA, Al-Sabbagh, M. Bioactive glass three decades on. J Long Term Eff Med Implants. 2005; 15: 585-597. |
.jpg)
.jpg)
.jpg)